No headlines found.
No press releases found.
No news found.
Drugs Made In America Acquisition Corp. - Units trades on the stock market under the symbol DMAAU.
As of March 2, 2026, DMAAU stock price was flat at $10.50 with 103 million shares trading.
DMAAU has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
DMAAU has underperformed the market in the last year with a price return of +3.9% while the SPY ETF gained +18.6%. DMAAU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.1% and -0.5%, respectively, while the SPY returned +1.3% and +0.7%, respectively.
DMAAU support price is $10.48 and resistance is $10.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMAAU shares will trade within this expected range on the day.
